PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
04-Jan-2022 Altasciences Acquires Sinclair Research and Continues to Expand Preclinical Platform Businesswire
04-Jan-2022 Virpax® Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference Businesswire
04-Jan-2022 PharmaJet partner Zydus Cadila Announces COVID-19 Vaccine Expansion Plan to Multiple Countries With Korean Firm Businesswire
04-Jan-2022 Insights on the Probiotics Packaging Global Market (2021 to 2031) - Featuring Amcor, Sonoco Products and Flex-Pack Among Others - ResearchAndMarkets.com Businesswire
04-Jan-2022 John Maraganore Joins the n-Lorem Foundation Team as Chair of Its Advisory Council Businesswire
04-Jan-2022 PharmaCyte Biotech Study Proves Capsule Material Is Not Toxic For Encapsulated Cells Businesswire
04-Jan-2022 Artiva Biotherapeutics Strengthens Leadership Team with the Appointment of Christopher Horan as Chief Technical Operations Officer Businesswire
04-Jan-2022 ImmunityBio Awarded Seminal Patent on Natural Killer Cells Businesswire
04-Jan-2022 Merger of Kalexsyn, Inc. into Dipharma Inc. Businesswire
04-Jan-2022 Legend Biotech to Participate in the 40th Annual J.P. Morgan Healthcare Conference Businesswire
04-Jan-2022 Full-Life Technologies Announces Senior Executive Team Appointments Businesswire
04-Jan-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
04-Jan-2022 ArsenalBio to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference Businesswire
04-Jan-2022 Equillium Announces Publication of Data in the Journal of Clinical Investigation Highlighting the Importance of the CD6-ALCAM Pathway in the Pathogenesis of Lupus Nephritis Businesswire
04-Jan-2022 Mojo Vision Partners With Fitness Brands to Elevate Sports and Fitness Experience and Performance via Its Smart Contact Lens Businesswire
04-Jan-2022 Melt Pharmaceuticals Submits INDs for MELT‑210 and MELT-400 to FDA Businesswire
04-Jan-2022 Exelixis Appoints Vicki L. Goodman, M.D., as Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer Businesswire
04-Jan-2022 Intrance Medical Systems Completes $17 Million Series A Financing and Appoints Ed Schutter to Board of Directors Businesswire
04-Jan-2022 Aldeyra Therapeutics Completes Enrollment in Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy Businesswire
04-Jan-2022 Equillium Announces Data from Phase 1b EQUIP Study in Patients with Uncontrolled Asthma Businesswire